Alternatives to Verve Therapeutics
Verve Therapeutics is a Biotechnology tool: developing gene editing therapies to lower cholesterol. Here are the 51 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Verve Therapeutics
Editas MedicineNot ratedA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
Intellia TherapeuticsNot ratedA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
FreenomeNot ratedFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
ImmunoScapeNot ratedDeveloping novel immunotherapies and diagnostics for cancer.
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Rocket PharmaceuticalsNot ratedA biotechnology company developing genetic therapies for rare disorders.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
Anagram TherapeuticsNot ratedClinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.
Latus BioNot ratedEngineering scalable gene therapies for broader patient populations.
Gossamer BioNot ratedA biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.
Showing the next 20 closest matches. See the rest on the Verve Therapeutics profile.
Sponsored rows are paid and labelled. Advertise on this page
